Sana Biotechnology SANA Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Sana Biotechnology’s reported figures.
Based on trailing twelve months.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's return on equity?
- Sana Biotechnology (SANA) reported return on equity of -147.4% in Q1 2026.
- How has Sana Biotechnology's return on equity changed year-over-year?
- Sana Biotechnology's return on equity decreased by 106.4% year-over-year, from -71.4% to -147.4%.
- What is the long-term trend for Sana Biotechnology's return on equity?
- Over 3 years (2022 to 2025), Sana Biotechnology's return on equity has grown at a 39.3% compound annual growth rate (CAGR), from -43.9% to -118.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.